{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:08:23Z","timestamp":1761646103541},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,29]]},"DOI":"10.7759\/cureus.17540","type":"journal-article","created":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T17:11:52Z","timestamp":1630257112000},"source":"Crossref","is-referenced-by-count":1,"title":["Guillain-Barr\u00e9 Syndrome Presenting as an Acute Back Pain"],"prefix":"10.7759","author":[{"given":"Nicholas T","family":"Hodgeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacy E","family":"Lowry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sky D","family":"Graybill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-673667665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"5","author":"Hughes RA","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barr\u00e9 syndrome. Lancet. 2005, 5:1653-66. 10.1016\/S0140-673667665-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar JJ","year":"2011","unstructured":"Sejvar JJ, Kohl KS, Gidudu J, et al.. Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011, 29:599-612. 10.1016\/j.vaccine.2010.06.003","journal-title":"Vaccine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1515\/med-2018-0074","article-title":"Guillain-Barr\u00e9 syndrome and low back pain: two cases and literature review","volume":"13","author":"Ding X","year":"2018","unstructured":"Ding X, Jiang H, Hu X, Ren H, Cai H. Guillain-Barr\u00e9 syndrome and low back pain: two cases and literature review. Open Med (Wars). 2018, 13:503-8. 10.1515\/med-2018-0074","journal-title":"Open Med (Wars)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar JJ","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011, 36:123-33. 10.1159\/000324710","journal-title":"Neuroepidemiology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3329\/jhpn.v28i6.6602","article-title":"Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review","volume":"28","author":"Poropatich KO","year":"2010","unstructured":"Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review. J Health Popul Nutr. 2010, 28:545-52. 10.3329\/jhpn.v28i6.6602","journal-title":"J Health Popul Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden RD","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP, et al.. Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome. Neurology. 2001, 56:758-65. 10.1212\/wnl.56.6.758","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs BC","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology. 1998, 51:1110-5. 10.1212\/wnl.51.4.1110","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA . Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke C","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014, 137:33-43. 10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.3.813","article-title":"Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barr\u00e9 syndrome","volume":"47","author":"Gorson KC","year":"1996","unstructured":"Gorson KC, Ropper AH, Muriello MA, Blair R. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barr\u00e9 syndrome. Neurology. 1996, 47:813-7. 10.1212\/wnl.47.3.813","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.44.7.1334","article-title":"Magnetic resonance imaging of the cauda equina in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Crino PB","year":"1994","unstructured":"Crino PB, Zimmerman R, Laskowitz D, Raps EC, Rostami AM. Magnetic resonance imaging of the cauda equina in Guillain-Barr\u00e9 syndrome. Neurology. 1994, 44:1334-6. 10.1212\/wnl.44.7.1334","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.43.3_part_1.618","article-title":"Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy","volume":"43","author":"Morgan GW","year":"1993","unstructured":"Morgan GW, Barohn RJ, Bazan C 3rd, King RB, Klucznik RP. Nerve root enhancement with MRI in inflammatory demyelinating polyradiculoneuropathy. Neurology. 1993, 43:618-20. 10.1212\/wnl.43.3_part_1.618","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/BF00588081","article-title":"Magnetic resonance imaging of nerve root inflammation in the Guillain-Barr\u00e9 syndrome","volume":"36","author":"Perry JR","year":"1994","unstructured":"Perry JR, Fung A, Poon P, Bayer N. Magnetic resonance imaging of nerve root inflammation in the Guillain-Barr\u00e9 syndrome. Neuroradiology. 1994, 36:139-40. 10.1007\/BF00588081","journal-title":"Neuroradiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"19","author":"Hughes RA","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014, 19:002063. 10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","unstructured":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet. 1997, 349:225-30. 10.1016\/S0140-6736(96)09095-2","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490060092030","article-title":"What can the history and physical examination tell us about low back pain?","volume":"268","author":"Deyo RA","year":"1992","unstructured":"Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain?. JAMA. 1992, 268:760. 10.1001\/jama.1992.03490060092030","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00010","article-title":"Diagnostic evaluation of low back pain with emphasis on imaging","volume":"137","author":"Jarvik JG","year":"2002","unstructured":"Jarvik JG, Deyo RA. Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med. 2002, 137:586-97. 10.7326\/0003-4819-137-7-200210010-00010","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/52305-guillain-barr-syndrome-presenting-as-an-acute-back-pain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:29Z","timestamp":1707507269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/52305-guillain-barr-syndrome-presenting-as-an-acute-back-pain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.17540","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,29]]}}}